Medications
FDA OKs Merck drug, first in new cancer drug class (Update)
Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments.
Sep 4, 2014
0
0
News tagged with merck
Medications
FDA approves new sleeping drug from Merck (Update)
Merck & Co. Inc. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.
Aug 13, 2014
0
0
Medications
Merck to pay $3.85B for hepatitis C drug developer
Merck & Co. will spend about $3.85 billion for Idenix Pharmaceuticals Inc., a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly ...
Jun 9, 2014
0
0
Other
$100 million NuvaRing settlement finalized
A $100 million settlement involving NuvaRing, a birth-control device linked to sometimes-fatal side effects, will stand now that enough claimants have chosen to opt into the agreement.
Jun 5, 2014
0
0
Medications
Merck: New drugs pending approval or in late tests
Merck & Co. could get an impressive six new prescription medicines approved in the U.S. this year and will soon apply for regulatory approval of two others, company executives said Tuesday during a briefing on Merck's business.
May 6, 2014
0
0
Medications
Bayer to buy Merck consumer business for $14.2B
Germany's Bayer plans to buy U.S.-based Merck & Co.'s consumer health business, creating a combined medicine cabinet of household names from Bayer's aspirin to Merck's Claritin allergy pills.
May 6, 2014
0
0
Other
Merck 1Q profit up 7 pct. despite sales decline
Major cost cuts enabled drugmaker Merck & Co. to offset lower first-quarter sales as generic competition continues to hurt sales of former blockbuster medicines. Merck's profit rose 7 percent, trouncing Wall Street expectations.
Apr 29, 2014
0
0
Medications
FDA OKs Merck tablet to reduce ragweed allergies
U.S. regulators have again approved a Merck & Co. tablet for gradually reducing seasonal allergies, this time for ragweed pollen.
Apr 17, 2014
0
0
Immunology
FDA OKs Merck tablet to reduce grass allergies
Merck & Co. says the Food and Drug Administration has approved its new tablet for grass allergies, Grastek, for patients five to 65 years old.
Apr 15, 2014
0
0
Medications
Merck to offer 100 million settlement in NuvaRing lawsuits
(HealthDay)—Merck will pay $100 million to settle thousands of lawsuits over the company's NuvaRing birth control device, according to insiders.
Feb 10, 2014
0
0
